Literature DB >> 22850540

Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin.

Wenhao Cui1, Miao Wang, Hitoshi Maegawa, Yuga Teranishi, Norifumi Kawada.   

Abstract

BACKGROUND: The activation of hepatic stellate cells plays a central role in the development of liver fibrosis during chronic liver trauma. The aim of the present study was to identify a compound that inhibits the activation process of stellate cells.
METHODS: Rat primary cultured stellate cells and a human stellate cell line (LX-2) were used. The effects of arundic acid on the expression of α-smooth muscle actin, collagen 1α1, and cytoglobin were evaluated.
RESULTS: Arundic acid (300 μM) inhibited the activation of primary rat stellate cells, as determined by morphological transformation and α-smooth muscle actin expression, after both prophylactic and therapeutic treatment. The level of α-smooth muscle actin mRNA showed a dose-dependent decrease in response to arundic acid, and 50 μM arundic acid exhibited the maximum inhibition of collagen 1α1 mRNA expression. In contrast, arundic acid triggered an unexpected increase in mRNA and protein levels of cytoglobin, the fourth globin in mammals expressed exclusively in hepatic stellate cells. The effect of arundic acid on the level of α-smooth muscle actin mRNA was abrogated in HSCs treated with cytoglobin siRNA. Arundic acid decreased the expression of collagen 1α1 mRNA in LX-2 cells.
CONCLUSION: Arundic acid affects the activation process of hepatic stellate cells via the unexpected induction of cytoglobin.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850540     DOI: 10.1016/j.bbrc.2012.07.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism.

Authors:  Yuga Teranishi; Tsutomu Matsubara; Kristopher W Krausz; Thi T T Le; Frank J Gonzalez; Katsutoshi Yoshizato; Kazuo Ikeda; Norifumi Kawada
Journal:  Lab Invest       Date:  2015-02-16       Impact factor: 5.662

2.  Arundic Acid Prevents Developmental Upregulation of S100B Expression and Inhibits Enteric Glial Development.

Authors:  Marlene M Hao; Elena Capoccia; Carla Cirillo; Werend Boesmans; Pieter Vanden Berghe
Journal:  Front Cell Neurosci       Date:  2017-02-23       Impact factor: 5.505

3.  Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.

Authors:  Yi-Yuan Zheng; Miao Wang; Xiang-Bing Shu; Pei-Yong Zheng; Guang Ji
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

4.  A modified method for isolating human quiescent pancreatic stellate cells.

Authors:  Fu-Tao Meng; Mei Huang; Fang-Fang Fan; Feng Shao; Chao Wang; Qiang Huang
Journal:  Cancer Manag Res       Date:  2019-02-14       Impact factor: 3.989

5.  Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule.

Authors:  Miao Wang; Shanshan Sun; Tao Wu; Li Zhang; Haiyan Song; Weiwei Hao; Peiyong Zheng; Lianjun Xing; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

Review 6.  Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management.

Authors:  Tatsha C Bholah; Vidushi S Neergheen-Bhujun; Nikolas J Hodges; Sabrina D Dyall; Theeshan Bahorun
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

7.  Cytoglobin expression in the hepatic stellate cell line HSC-T6 is regulated by extracellular matrix proteins dependent on FAK-signalling.

Authors:  Louise Catherine Stone; Lorna Susan Thorne; Christopher John Weston; Mark Graham; Nikolas John Hodges
Journal:  Fibrogenesis Tissue Repair       Date:  2015-08-21

Review 8.  Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts.

Authors:  Norifumi Kawada
Journal:  Front Physiol       Date:  2015-11-13       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.